[Allergic bronchopulmonary aspergillosis in a patient with diabetes mellitus as the only risk factor].
| Autor: | Hernández-Solís A; Servicio de Neumología y Cirugía de Tórax. drhernandezsolis@yahoo.com.mx., Velázquez-Sámano G; Servicio de Alergia e Inmunología. Hospital General de México Dr. Eduardo Liceaga, Ciudad de México., Apolinar-Juárez V; Servicio de Alergia e Inmunología. Hospital General de México Dr. Eduardo Liceaga, Ciudad de México., Mojica Jaimes E; Servicio de Neumología y Cirugía de Tórax.; Universidad Anáhuac México, Ciudad de México., Serna Valle FJ; Servicio de Neumología y Cirugía de Tórax.; Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México (UNAM), Tlalnepantla, Estado de México., Velazquez Gachuz YM; Servicio de Neumología y Cirugía de Tórax; Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México (UNAM), Tlalnepantla, Estado de México.; Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México (UNAM), Tlalnepantla, Estado de México. |
|---|---|
| Jazyk: | Spanish; Castilian |
| Zdroj: | Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) [Rev Alerg Mex] 2024 Sep 30; Vol. 71 (3), pp. 212-215. Date of Electronic Publication: 2024 Sep 30. |
| DOI: | 10.29262/ram.v71i3.1383 |
| Abstrakt: | Background: Allergic bronchopulmonary aspergillosis is a rare entity, caused by a hypersensitivity reaction of the immune system to Aspergillus fumigatus, characterized by the presence of pulmonary infiltrates, bronchiectasis and increased eosinophils in peripheral blood. Case Report: 42-year-old male with diabetes mellitus, with poor adherence to treatment, went to the emergency room due to rapidly progressive dyspnea and severe hypoxemia, pneumonia and bilateral pleural effusion were evident, laboratory studies reported, HbA1c 9.4%, eosinophils 3650 cells/mL, serum IgE for Aspergillus fumigatus 0.84 IU/mL. Treatment was started with supplemental oxygen, prednisone and itraconazole, to which the patient showed clinical and radiological improvement. Conclusions: Invasive mycoses have a mortality of 21 to 80%, frequently in immunocompromised patients, they are usually not described in patients with diabetes mellitus; The prevalence of fungal colonization among diabetic patients has been described as 37% compared to 4.7% in non-diabetic patients. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|